The Cigna Group — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b0cb1f47-2bea-4026-ae44-5f7337943e73/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $274.9B | 2025-01-01 – 2025-12-31 | evidence 0001739940-26-000006 |
| FY 2024 | $247.1B | 2024-01-01 – 2024-12-31 | evidence 0001739940-25-000009 |
| FY 2023 | $195.3B | 2023-01-01 – 2023-12-31 | evidence 0001739940-24-000005 |
| FY 2022 | $180.5B | 2022-01-01 – 2022-12-31 | evidence 0001739940-24-000005 |
| FY 2021 | $174.1B | 2021-01-01 – 2021-12-31 | evidence 0001739940-24-000005 |
| FY 2020 | $160.4B | 2020-01-01 – 2020-12-31 | evidence 0001739940-21-000007 |
| FY 2019 | $153.6B | 2019-01-01 – 2019-12-31 | evidence 0001739940-20-000006 |
| FY 2018 | $48.6B | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-000792 |
| FY 2017 | $41.8B | 2017-01-01 – 2017-12-31 | evidence 0001047469-19-000792 |
| FY 2016 | $39.8B | 2016-01-01 – 2016-12-31 | evidence 0001047469-19-000792 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).